1.What is the update of MVision AI?
MVision AI, a Finnish medical imaging and AI firm, aims to expedite cancer treatment planning while maintaining high-quality care. Our method uses AI-powered automatic segmentation technology to streamline the crucial workflow of radiation treatment planning. The business revealed today that it has acquired post-seed financing for $5.85 million (€5.4 million).
2.why MVision AI is important?
MVision’s automation allows for same-day treatment, as opposed to manual treatment planning, which frequently necessitates two to three weeks of tense waiting before radiotherapy treatment planning begins.
3.How is the growth of MVision?
It was reported that 44% of breast cancer scans were prepared to be scheduled on the same day after the implementation of MVision AI. Only 10% of the scans were ready to be scheduled the same day without MVision AI.
MVision now has a staff of more than 30 experts, many of which have strong histories in the medical sector and AI research. According to the business, over 100,000 cancer patients have received treatment using its technology in 14 different countries, and several facilities, like the Gainesville Department of Radiation Oncology at the University of Florida, have seen a considerable decrease in wait times.